Comprehensive Psychiatry
Volume 41, Issue 2, Supplement 1 , Pages 86-89, March 2000

Subthreshold symptoms and vulnerability indicators (e.g., eye tracking dysfunction) in Schizophrenia

  • Klaus-Malte Flechtner

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Klaus-Malte Flechtner, M.D., Psychiatrische Klinik und Poliklinik der Freien Universität Berlin, Abteilung für Sozialpsychiatrie, Platanenallee 19, 14050 Berlin.
    • From the Psychiatrische Klinik und Poliklinik der Freien Universität Berlin, Abteilung für Sozialpsychiatrie, Berlin; and Kliniken im Theodor-Wenzel-Werk, Berlin, Germany.
  • ,
  • Bruno Steinacher

      Affiliations

    • From the Psychiatrische Klinik und Poliklinik der Freien Universität Berlin, Abteilung für Sozialpsychiatrie, Berlin; and Kliniken im Theodor-Wenzel-Werk, Berlin, Germany.
  • ,
  • Arthur Mackert

      Affiliations

    • From the Psychiatrische Klinik und Poliklinik der Freien Universität Berlin, Abteilung für Sozialpsychiatrie, Berlin; and Kliniken im Theodor-Wenzel-Werk, Berlin, Germany.

Subthreshold symptoms in schizophrenia can be prodromal signs of a psychotic relapse. In people without schizophrenia, similar symptoms may indicate the presence of disorders termed schizophrenia spectrum disorders. Subthreshold schizophrenia-like symptoms may indicate a genetically transmitted higher proneness to schizophrenia. Such a higher liability to develop schizophrenia is ascertained on a symptom level. In genetic studies, asymptomatic members of a pedigree are therefore classified as unaffected although they may possess the genes in question. On a biological level, eye tracking dysfunction has been shown to fulfill certain criteria for a vulnerability indicator and therefore promises to offer more information on genetically transmitted proneness to schizophrenia even in people without psychopathological symptoms. Subthreshold symptoms may warrant treatment. The database for prophylactic treatment in populations at high risk, especially those without symptoms, is currently very small.

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0010-440X(00)80013-9

Comprehensive Psychiatry
Volume 41, Issue 2, Supplement 1 , Pages 86-89, March 2000